8/5/2023 0 Comments Abbott istat fda approvalAbbott's blood test will give healthcare professionals an objective tool for evaluating people suspected of having an injury to the brain.©2023 Abbott. These effects are worsened by misdiagnosis or lack of diagnosis. People who sustain a TBI are more likely to have another one – similarly to how a sprained ankle or torn ligament is more susceptible to future injury. Effects of TBI can last anywhere from a few days post-injury or may be permanent. Survivors of TBI may experience impairment of memory, movement, sensation (e.g., vision and hearing), and emotional functioning (e.g., personality changes, psychological symptoms). A test like this could encourage more people to get tested after a head trauma, which is important, because not receiving a diagnosis can be dangerous and may prevent people from taking the necessary steps to recover safely." "And beyond those who go to the hospital for a suspected TBI, many more never do. "Evaluating brain injuries is complex – and research shows that we only catch about half of those who show up to the hospital with a suspected TBI," said Geoffrey Manley, M.D., Ph.D., vice chair of neurological surgery at the University of California, San Francisco. Nearly 5 million people go to the emergency room for a TBI in the U.S. This is part of Abbott's strategy to ensure that its tests are available both in the lab and in other settings where people need immediate answers and care. Our vision for the future is that we'd have a 15-minute, portable test that can be used outside the traditional healthcare setting where people experience head injuries and need a quick evaluation, like sporting events.Ībbott has also received FDA breakthrough designation – which speeds assessment of tests through increased FDA interaction – for a TBI test that would run on its Alinity i and Architect core laboratory instruments. The cartridge is then inserted into the handheld instrument.Įvaluating brain injuries is complex – and research shows that we only catch about half of those who show up to the hospital with a suspected TBI Geoffrey ManleyĪbbott is also working on a whole blood test, which would eliminate the need for separation of plasma and could be used at the patient's side in a healthcare setting. The test requires a small blood sample drawn from the arm, from which plasma is extracted with a centrifuge and applied to the test's cartridge. "You can't treat what you don't know and now physicians will be equipped with critical, objective information that will help them provide the best care possible, allowing patients to take steps to recover, prevent reinjury and get back to doing the things they care about most." "Healthcare providers have been waiting for a blood test for the brain and now we have one," said Beth McQuiston, M.D., medical director for Abbott's diagnostics business. For those who test positive, this test result complements CT scans to help clinicians evaluate whether someone has a TBI. A negative result on this test can be used to rule out the need for a head CT scan, a common tool used to diagnose concussion. This test measures specific proteins present in the blood after a TBI. TBIs, including concussions, are an alteration in brain function caused by an external force. Tests results are available within 15 minutes after plasma is placed in the test cartridge. The test will run on Abbott's handheld i-STAT Alinity platform.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |